The justices are set to hear Hikma v. Amarin, a battle over drug patents that could raise costs for patients and change the way generic companies do business.
The United States pays undeniably high prices for brand-name drugs. But when it comes to generics — the cheaper copycat medicines that now fill nine out of every 10 prescriptions in America — the country gets a very good deal.
Americans pay less, on … [6088 chars]
Source: NPR | Published: 2026-04-29T09:00:00Z
Credit: NPR
